Trials / Completed
CompletedNCT01038830
QuantiFERON Change During Anti-tuberculosis Medication
The Change in Level of Interferon-gamma Assay in Active Tuberculosis Patients During Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Armed Forces Capital Hospital, Republic of Korea · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the change of QuantiFERON-TB gold in tube assay (QFT) during the treatment of active tuberculosis.
Detailed description
Patients with active pulmonary tuberculosis are enrolled and, QFTs are performed for each subjects before treatment and 1, 3, 6 months after treatment. Investigators check the level of interferon-gamma, and reversion and conversion of this test.
Conditions
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2010-04-01
- Completion
- 2010-05-01
- First posted
- 2009-12-24
- Last updated
- 2010-06-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01038830. Inclusion in this directory is not an endorsement.